Biotech | April 03, 2022
New data indicate molnupiravir eliminates Covid-19 rapidly
Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10
Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
In May 2021, Daiichi Sankyo had submitted a supplemental new drug application (sNDA) for Tarlige tablets based on results from a phase 3 trial in patients with CNP
More than 120 speakers and 5,000 delegates are expected to attend
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
Subscribe To Our Newsletter & Stay Updated
